WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ATHA

Based on 2 analysts offering 12 month price targets for Athira Pharma Inc.
Min Forecast
$19.00+3,412.01%
Avg Forecast
$20.50+3,689.28%
Max Forecast
$22.00+3,966.54%

Should I buy or sell ATHA stock?

Based on 2 analysts offering ratings for Athira Pharma Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHA stock forecasts and price targets.

ATHA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-19
lockedlocked$00.00+00.00%2024-06-20

1 of 1

Forecast return on equity

Is ATHA forecast to generate an efficient return?
Company
-144.38%
Industry
-388.81%
Market
59.09%
ATHA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATHA forecast to generate an efficient return on assets?
Company
-108.15%
Industry
27.33%
ATHA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATHA earnings per share forecast

What is ATHA's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.56
Avg 2 year Forecast
-$2.97
Avg 3 year Forecast
-$2.80

ATHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHA$0.54$20.50+3,689.28%Strong Buy
MEIP$3.10$7.00+125.81%Hold
BCLI$0.26$2.00+675.19%Strong Buy
VINC$0.71N/AN/A
PHGE$1.19$22.50+1,790.76%Strong Buy
View Top Biotech Stocks

Athira Pharma Stock Forecast FAQ

Is Athira Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ATHA) stock is to Strong Buy ATHA stock.

Out of 2 analysts, 1 (50%) are recommending ATHA as a Strong Buy, 1 (50%) are recommending ATHA as a Buy, 0 (0%) are recommending ATHA as a Hold, 0 (0%) are recommending ATHA as a Sell, and 0 (0%) are recommending ATHA as a Strong Sell.

If you're new to stock investing, here's how to buy Athira Pharma stock.

What is ATHA's earnings growth forecast for 2024-2026?

(NASDAQ: ATHA) Athira Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Athira Pharma's earnings in 2024 is -$113,451,000.On average, 2 Wall Street analysts forecast ATHA's earnings for 2024 to be -$98,404,800, with the lowest ATHA earnings forecast at -$99,557,981, and the highest ATHA earnings forecast at -$97,251,619. On average, 2 Wall Street analysts forecast ATHA's earnings for 2025 to be -$113,972,747, with the lowest ATHA earnings forecast at -$129,925,088, and the highest ATHA earnings forecast at -$98,020,406.

In 2026, ATHA is forecast to generate -$107,630,250 in earnings, with the lowest earnings forecast at -$107,630,250 and the highest earnings forecast at -$107,630,250.

What is ATHA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ATHA) forecast ROE is -144.38%, which is considered weak.

What is ATHA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ATHA price target, the average ATHA price target is $20.50, with the highest ATHA stock price forecast at $22.00 and the lowest ATHA stock price forecast at $19.00.

On average, Wall Street analysts predict that Athira Pharma's share price could reach $20.50 by Aug 19, 2025. The average Athira Pharma stock price prediction forecasts a potential upside of 3,689.28% from the current ATHA share price of $0.54.

What is ATHA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ATHA) Athira Pharma's current Earnings Per Share (EPS) is -$2.97. On average, analysts forecast that ATHA's EPS will be -$2.56 for 2024, with the lowest EPS forecast at -$2.59, and the highest EPS forecast at -$2.53. On average, analysts forecast that ATHA's EPS will be -$2.97 for 2025, with the lowest EPS forecast at -$3.38, and the highest EPS forecast at -$2.55. In 2026, ATHA's EPS is forecast to hit -$2.80 (min: -$2.80, max: -$2.80).

What is ATHA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ATHA) forecast ROA is -108.15%, which is lower than the forecast US Biotechnology industry average of 27.33%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.